Prostatis Group LLC purchased a new position in shares of iShares MSCI Emerging Markets ETF ( NYSEARCA:EEM – Get Rating ) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 73,015 shares of the exchange traded fund's stock, valued at approximately $2,767,000. iShares MSCI Emerging Markets ETF makes up approximately 1.6% of Prostatis Group LLC's portfolio, making the stock its 15th biggest position. Other institutional investors and hedge funds have also recently bought and sold shares of the company.

https://www.dailypolitical.com/2023/06/16/prostatis-group-llc-invests-2-77-million-in-ishares-msci-emerging-markets-etf-nysearcaeem.html

#dailypolitical